{"id":4382,"date":"2023-03-07T13:17:22","date_gmt":"2023-03-07T12:17:22","guid":{"rendered":"https:\/\/blogs.bmj.com\/medical-ethics\/?p=4382"},"modified":"2023-03-07T13:17:22","modified_gmt":"2023-03-07T12:17:22","slug":"re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/","title":{"rendered":"Re-thinking consent for treatment: clinical interests and the public interest"},"content":{"rendered":"

By Abeezar I. Sarela.<\/p>\n

In its recent guidance on consent, the General Medical Council (GMC)<\/a> advises doctors to not provide treatment that \u2018you (the doctor) don\u2019t think would be in their (the patient\u2019s) clinical interests\u2019. It follows that doctors should only provide treatments that are in the patient\u2019s clinical interests. But, what exactly is meant by \u2018clinical interests\u2019?<\/p>\n

The GMC does not explain the term. In practice, it is sometimes confused with \u2018best interests\u2019. However, best interests<\/a> is a legal term that applies specifically to making decisions for people who lack the capacity to do so for themselves. For example, oncologists might consider that either chemotherapy A or chemotherapy B could be in the clinical interests of a patient without capacity. Best interest decision-making would then involve choosing between A and B, or avoiding any chemotherapy and giving supportive care only. Whereas, patients with capacity would make these choices for themselves and do not need others to decide their best interests.<\/p>\n

The difference between clinical interests and best interests is similar to that between setting a menu and then choosing from that menu. Clinical interests set the menu of treatment options that is available to a patient. Patients can then choose any option from this menu or decline all options, regardless of the consequences, because we all have a right of self-determination. But, do patients have a right to participate in setting the menu, too? Some might say yes. They would argue that treatment availability comes down to a matter of informed consent, through a process of shared decision-making (SDM)<\/a> between the doctor and the patient.<\/p>\n

However, senior judges have been clear that consent is valid only if the proposed treatment is, in the first place, \u2018proper\u2019<\/a>. If the treatment is not proper, then the patient\u2019s consent is meaningless, regardless of the sharing of information. In other words, setting the menu is not a matter for SDM. Rather, informed consent has two distinct stages<\/a>. In the first stage, the doctor has to identify treatments that are proper (reasonable or available) for that patient. Then, the doctor has to involve the patient in the choosing between available treatments (or not having any treatment). It is this second stage that requires SDM: a dialogue about the menu of available treatments from the first stage.<\/p>\n

What is it that makes a treatment available in the first place? Judges have explained that for a treatment to be available it has to be in the \u2018public interest\u2019<\/a>. This turn to public interest can be justified in various ways<\/a>. In a civilised society, we all (the \u2018public\u2019) have an interest in each other\u2019s welfare. And, in some cases, the public interest can override an individual\u2019s own wishes. Furthermore, in a publicly-funded health service it is inescapable that making treatment available to one person reduces resources for others. Consequently, it is in the public interest to set limits on availability of treatment.<\/p>\n

The GMC would seem to have re-phrased \u2018public interest\u2019 as \u2018clinical interests\u2019. The endpoint of both is the same: the identification of available treatments. Thus, in advising doctors to think about a patient\u2019s clinical interests, the GMC is actually asking doctors to consider the public interest. The GMC leaves this task to the professional judgment of doctors; and judges have done similarly. This approach is consistent with a well-established sociological argument<\/a> that the public grants the medical profession with the authority to make certain decisions on its behalf. As doctors, let\u2019s celebrate this sociological mandate and strive to serve the public. Or let\u2019s challenge it, and find an alternative way. But, in the meanwhile, let\u2019s not hide behind smokescreens of SDM and consent to decide about the availability of treatment.<\/p>\n

Author:\u00a0<\/strong>Abeezar I. Sarela<\/p>\n

Affiliation: <\/strong>Department of Surgery, The Leeds Teaching Hospitals NHS Trust.<\/p>\n

Competing interests<\/strong>: None declared<\/p>\n","protected":false},"excerpt":{"rendered":"

By Abeezar I. Sarela. In its recent guidance on consent, the General Medical Council (GMC) advises doctors to not provide treatment that \u2018you (the doctor) don\u2019t think would be in their (the patient\u2019s) clinical interests\u2019. It follows that doctors should only provide treatments that are in the patient\u2019s clinical interests. But, what exactly is meant […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":354,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8053,8076,8088,8057],"tags":[],"class_list":["post-4382","post","type-post","status-publish","format-standard","hentry","category-consent","category-decision-making","category-healthcare","category-medical-ethics"],"yoast_head":"\nRe-thinking consent for treatment: clinical interests and the public interest - Journal of Medical Ethics blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Re-thinking consent for treatment: clinical interests and the public interest - Journal of Medical Ethics blog\" \/>\n<meta property=\"og:description\" content=\"By Abeezar I. Sarela. In its recent guidance on consent, the General Medical Council (GMC) advises doctors to not provide treatment that \u2018you (the doctor) don\u2019t think would be in their (the patient\u2019s) clinical interests\u2019. It follows that doctors should only provide treatments that are in the patient\u2019s clinical interests. But, what exactly is meant [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/\" \/>\n<meta property=\"og:site_name\" content=\"Journal of Medical Ethics blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-07T12:17:22+00:00\" \/>\n<meta name=\"author\" content=\"Hazem Zohny\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hazem Zohny\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/\"},\"author\":{\"name\":\"Hazem Zohny\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/person\\\/e73152f6aa4e164c7d625d77cf4fed35\"},\"headline\":\"Re-thinking consent for treatment: clinical interests and the public interest\",\"datePublished\":\"2023-03-07T12:17:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/\"},\"wordCount\":653,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#organization\"},\"articleSection\":[\"consent\",\"Decision making\",\"healthcare\",\"Medical ethics\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/\",\"name\":\"Re-thinking consent for treatment: clinical interests and the public interest - Journal of Medical Ethics blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#website\"},\"datePublished\":\"2023-03-07T12:17:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2023\\\/03\\\/07\\\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Re-thinking consent for treatment: clinical interests and the public interest\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/\",\"name\":\"Journal of Medical Ethics blog\",\"description\":\"A blog to discuss the ethics of medicine in its many guises and formats.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#organization\",\"name\":\"Journal of Medical Ethics blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/files\\\/2026\\\/04\\\/jme-logo.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/files\\\/2026\\\/04\\\/jme-logo.png\",\"width\":200,\"height\":50,\"caption\":\"Journal of Medical Ethics blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/person\\\/e73152f6aa4e164c7d625d77cf4fed35\",\"name\":\"Hazem Zohny\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d1bd322d5ff8e6f31a624003143903d0ba7346af8cdb1fd6b5e95924b92ece1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d1bd322d5ff8e6f31a624003143903d0ba7346af8cdb1fd6b5e95924b92ece1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d1bd322d5ff8e6f31a624003143903d0ba7346af8cdb1fd6b5e95924b92ece1?s=96&d=mm&r=g\",\"caption\":\"Hazem Zohny\"},\"sameAs\":[\"https:\\\/\\\/www.practicalethics.ox.ac.uk\\\/people\\\/dr-hazem-zohny\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/author\\\/zohnyh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Re-thinking consent for treatment: clinical interests and the public interest - Journal of Medical Ethics blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/","og_locale":"en_US","og_type":"article","og_title":"Re-thinking consent for treatment: clinical interests and the public interest - Journal of Medical Ethics blog","og_description":"By Abeezar I. Sarela. In its recent guidance on consent, the General Medical Council (GMC) advises doctors to not provide treatment that \u2018you (the doctor) don\u2019t think would be in their (the patient\u2019s) clinical interests\u2019. It follows that doctors should only provide treatments that are in the patient\u2019s clinical interests. But, what exactly is meant [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/","og_site_name":"Journal of Medical Ethics blog","article_published_time":"2023-03-07T12:17:22+00:00","author":"Hazem Zohny","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Hazem Zohny","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/"},"author":{"name":"Hazem Zohny","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/person\/e73152f6aa4e164c7d625d77cf4fed35"},"headline":"Re-thinking consent for treatment: clinical interests and the public interest","datePublished":"2023-03-07T12:17:22+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/"},"wordCount":653,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#organization"},"articleSection":["consent","Decision making","healthcare","Medical ethics"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/","url":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/","name":"Re-thinking consent for treatment: clinical interests and the public interest - Journal of Medical Ethics blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#website"},"datePublished":"2023-03-07T12:17:22+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2023\/03\/07\/re-thinking-consent-for-treatment-clinical-interests-and-the-public-interest\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/medical-ethics\/"},{"@type":"ListItem","position":2,"name":"Re-thinking consent for treatment: clinical interests and the public interest"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#website","url":"https:\/\/blogs.bmj.com\/medical-ethics\/","name":"Journal of Medical Ethics blog","description":"A blog to discuss the ethics of medicine in its many guises and formats.","publisher":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/medical-ethics\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#organization","name":"Journal of Medical Ethics blog","url":"https:\/\/blogs.bmj.com\/medical-ethics\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/medical-ethics\/files\/2026\/04\/jme-logo.png","contentUrl":"https:\/\/blogs.bmj.com\/medical-ethics\/files\/2026\/04\/jme-logo.png","width":200,"height":50,"caption":"Journal of Medical Ethics blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/person\/e73152f6aa4e164c7d625d77cf4fed35","name":"Hazem Zohny","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4d1bd322d5ff8e6f31a624003143903d0ba7346af8cdb1fd6b5e95924b92ece1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4d1bd322d5ff8e6f31a624003143903d0ba7346af8cdb1fd6b5e95924b92ece1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4d1bd322d5ff8e6f31a624003143903d0ba7346af8cdb1fd6b5e95924b92ece1?s=96&d=mm&r=g","caption":"Hazem Zohny"},"sameAs":["https:\/\/www.practicalethics.ox.ac.uk\/people\/dr-hazem-zohny"],"url":"https:\/\/blogs.bmj.com\/medical-ethics\/author\/zohnyh\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/posts\/4382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/users\/354"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/comments?post=4382"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/posts\/4382\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/media?parent=4382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/categories?post=4382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/tags?post=4382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}